We have previously demonstrated that serosal bumetanide inhibits CFTR-mediated transepithelial Cl− secretion in HBECs from normal donors and that this response is absent from HBECs derived from CF donors with severe CFTR mutations [26]. The gene discussed is CFTR; the disease is cystic fibrosis.